Panacea Biotech signs agreement with Serum Institute for vaccine production
Panacea Biotec has signed an agreement with Serum Institute of India (SII) and its wholly owned subsidiary, Bilthovan Biologicals B.V. (BBIO). Under the agreement, SII […]
Panacea Biotec has signed an agreement with Serum Institute of India (SII) and its wholly owned subsidiary, Bilthovan Biologicals B.V. (BBIO). Under the agreement, SII […]
Panacea Biotec has entered into a joint collaboration with US generic drug maker Bionpharma Inc to develop, manufacture and sell seven complex generic drugs. The […]
Panacea Biotec has launched indigenously developed high quality oncology product, CABAPAN (Cabazitaxel Injection), for treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC). The company will […]
Copyright © 2024 | WordPress Theme by MH Themes